Circulating Myeloid Regulatory Cells: Promising Biomarkers in B-Cell Lymphomas

by Juliette Ferrant, Faustine Lhomme, Simon Le Gallou, Simon Le Gallou, Jonathan M. Irish, Jonathan M. Irish, Mikael Roussel, Mikael Roussel
Published 2021-02-01

In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment

by Amy T. Shah, Kirsten E. Diggins, Alex J. Walsh, Jonathan M. Irish, Melissa C. Skala
Published 2015-12-01

Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics

by David C. Earl, P. Brent Ferrell, Nalin Leelatian, Jordan T. Froese, Benjamin J. Reisman, Jonathan M. Irish, Brian O. Bachmann
Published 2018-01-01

Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy

by Sierra M Barone, Alberta GA Paul, Lyndsey M Muehling, Joanne A Lannigan, William W Kwok, Ronald B Turner, Judith A Woodfolk, Jonathan M Irish
Published 2021-08-01

HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior

by Maria-Fernanda Senosain, Yong Zou, Tatiana Novitskaya, Georgii Vasiukov, Aneri B. Balar, Dianna J. Rowe, Deon B. Doxie, Jonathan M. Lehman, Rosana Eisenberg, Fabien Maldonado, Andries Zijlstra, Sergey V. Novitskiy, Jonathan M. Irish, Pierre P. Massion
Published 2021-07-01

Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells

by Nalin Leelatian, Justine Sinnaeve, Akshitkumar M Mistry, Sierra M Barone, Asa A Brockman, Kirsten E Diggins, Allison R Greenplate, Kyle D Weaver, Reid C Thompson, Lola B Chambless, Bret C Mobley, Rebecca A Ihrie, Jonathan M Irish
Published 2020-06-01

CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation

by Kathryn E. Beckermann, Rachel Hongo, Xiang Ye, Kirsten Young, Katie Carbonell, Diana C. Contreras Healey, Peter J. Siska, Sierra Barone, Caroline E. Roe, Christof C. Smith, Benjamin G. Vincent, Frank M. Mason, Jonathan M. Irish, W. Kimryn Rathmell, Jeffrey C. Rathmell
Published 2020-08-01

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

by Douglas B. Johnson, Monica V. Estrada, Roberto Salgado, Violeta Sanchez, Deon B. Doxie, Susan R. Opalenik, Anna E. Vilgelm, Emily Feld, Adam S. Johnson, Allison R. Greenplate, Melinda E. Sanders, Christine M. Lovly, Dennie T. Frederick, Mark C. Kelley, Ann Richmond, Jonathan M. Irish, Yu Shyr, Ryan J. Sullivan, Igor Puzanov, Jeffrey A. Sosman, Justin M. Balko
Published 2016-01-01